Research Article
Synthesis and Antimicrobial Activity of Bis-4,6-sulfonamidated 5,7-Dinitrobenzofuroxans
Table 1
The in vitro antimicrobial activity of the synthesized compounds and the control drugs (1 mg/mL).
|
Compound number | Microorganisms, zone of inhibition (diameter, in mm) | Staphylococcus aureus | Escherichia сoli | Pseudomonas aeruginosa | Proteus mirabilis | Aspergillus niger | Candida albicans |
| 1 | 17 | — | — | — | 10 | 15 | Sulfanilamide (2) | 20 | 17 | 15 | 12 | 7 | 9 | 7 | 21 | 20 | 7 | 11 | 15 | 27 | 8 | 24 | 25 | 26 | 15 | 17 | 21 | 9 | 18 | 13 | 18 | 13 | 15 | 20 | 10 | 25 | 21 | 25 | 17 | 18 | 23 | 11 | 21 | 21 | 10 | 12 | 13 | 30 | Penicillin G | 21 | 20 | 8 | 10 | — | — | Rifampicin | 25 | 21 | — | — | — | — | Ketoconazole | — | — | — | — | 11 | 18 | Nystatin | — | — | — | — | 18 | 21 | DMSO | — | — | — | — | — | — |
|
|
Shown are mean values of triplicate tests; “—” indicates no significant inhibitory effect (<6 mm).
|